InChI=1S/C40H59NO11/c1- 19- 11- 24- 5- 7- 28- 20(2) 12- 26(45- 28) 9- 10- 40- 17- 33- 36(51- 40) 37- 38(50- 33) 39(52- 40) 35- 29(49- 37) 8- 6- 25(47- 35) 13- 22(42) 14- 27- 31(16- 30(46- 24) 21(19) 3) 48- 32(34(27) 44- 4) 15- 23(43) 18- 41/h19,23- 39,43H,2- 3,5- 18,41H2,1,4H3/t19- ,23+,24+,25- ,26+,27+,28+,29+,30- ,31+,32- ,33- ,34- ,35+,36+,37+,38- ,39+,40+/m1/s1 |
UFNVPOGXISZXJD-JBQZKEIOSA-N |
[H] [C@@] 12CC[C@] 3([H] ) O[C@@] ([H] ) (CC[C@@] 45C[C@] 6([H] ) O[C@] 7([H] ) [C@@] ([H] ) (O[C@@] 8([H] ) CC[C@] ([H] ) (CC(=O) C[C@] 9([H] ) [C@@H] (OC) [C@@H] (C[C@H] (O) CN) O[C@@] 9([H] ) C[C@@] ([H] ) (O1) C(=C) [C@H] (C) C2) O[C@] 8([H] ) [C@] 7([H] ) O4) [C@H] 6O5) CC3=C |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
microtubule-destabilising agent
Any substance that interacts with tubulin to inhibit polymerisation of microtubules.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
2- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- one
|
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,35R,36S)- 20- [(2S)- 3- amino- 2- hydroxypropyl]- 21- methoxy- 14- methyl- 8,15- bis(methylene)- 2,19,30,34,37,39,40,41- octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan- 24- one
|
IUPAC
|
253128-41-5
|
CAS Registry Number
|
ChemIDplus
|
9893060
|
Reaxys Registry Number
|
Reaxys
|
|